|

Copenhagen Baby Heart Study - Impact

RECRUITINGSponsored by Henning Bundgaard
Actively Recruiting
SponsorHenning Bundgaard
Started2018-11-01
Est. completion2029-07
Eligibility
Age1 Day – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05838079

Summary

Copenhagen Baby Heart Study - Impact (CBHS-I) is an extension to Copenhagen Baby Heart (CBH) which included over 25.000 new-borns in the Copenhagen area between 2016-2018. Based on clinical and subclinical deviations in the examinations in CBH, subgroups of participants will be invited to clinical examinations (echocardiography and electrocardiogram) in early childhood. There will also be a new, targeted inclusion based on certain exposures during pregnancy. The main objectives are to assess the prevalence of congenital and inherited heart disease and, and the development of these during early childhood; examining the association between pre- and postnatal exposure, disease, lifestyle, environmental and genetic factors; continue to establish reference values for echocardiography in Danish neonates and children.

Eligibility

Age: 1 Day – 99 YearsHealthy volunteers accepted
Inclusion Criteria:

* Participant in CBH or
* Family member of a participant in CBH or
* Born to mothers with pre-existing or gestational diabetes at either Rigshospitalet, Hvidovre Hospital, or Herlev Hospital during the period July 2020 through December 2023.

Exclusion Criteria:

* Faliure of providing concent (parents)

Conditions2

Congenital Heart DiseaseHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.